Seguir
Elisabeth Kapaki
Elisabeth Kapaki
National and Kapodistrian University of Athens, Medical School, 1st Department of Neurology
E-mail confirmado em med.uoa.gr
Título
Citado por
Citado por
Ano
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
16162015
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
4372011
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
4042013
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ...
Biomarkers in medicine 6 (4), 419-430, 2012
3492012
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
NA Verwey, WM Van Der Flier, K Blennow, C Clark, S Sokolow, ...
Annals of clinical biochemistry 46 (3), 235-240, 2009
2092009
A normative study of the trail making test A and B in Greek adults
I Zalonis, E Kararizou, NI Triantafyllou, E Kapaki, S Papageorgiou, ...
The Clinical Neuropsychologist 22 (5), 842-850, 2008
1862008
Highly increased CSF tau protein and decreased β-amyloid (1–42) in sporadic CJD: a discrimination from Alzheimer's disease?
E Kapaki, K Kilidireas, GP Paraskevas, M Michalopoulou, E Patsouris
Journal of Neurology, Neurosurgery & Psychiatry 71 (3), 401-403, 2001
1842001
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
1752018
Cerebrospinal fluid tau, phospho‐tau181 and β‐amyloid1−42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease
EN Kapaki, GP Paraskevas, NG Tzerakis, C Sfagos, A Seretis, ...
European journal of neurology 14 (2), 168-173, 2007
1622007
Circulating interleukin‐15 and RANTES chemokine in Parkinson’s disease
M Rentzos, C Nikolaou, E Andreadou, GP Paraskevas, A Rombos, ...
Acta Neurologica Scandinavica 116 (6), 374-379, 2007
1472007
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum
WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ...
JAMA neurology 79 (3), 228-243, 2022
1432022
Update on vascular cognitive impairment associated with subcortical small-vessel disease
A Wallin, GC Román, M Esiri, P Kettunen, J Svensson, GP Paraskevas, ...
Journal of Alzheimer's Disease 62 (3), 1417-1441, 2018
1342018
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
AH Simonsen, B Kuiperij, OMA El-Agnaf, S Engelborghs, SK Herukka, ...
Biomarkers in medicine 10 (1), 19-34, 2016
1212016
Circulating interleukin‐10 and interleukin‐12 in Parkinson’s disease
M Rentzos, C Nikolaou, E Andreadou, GP Paraskevas, A Rombos, ...
Acta Neurologica Scandinavica 119 (5), 332-337, 2009
1182009
Neurofilament ELISA validation
A Petzold, A Altintas, L Andreoni, A Bartos, A Berthele, MA Blankenstein, ...
Journal of immunological methods 352 (1-2), 23-31, 2010
1152010
CSF tau protein and β‐amyloid (1–42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population
E Kapaki, GP Paraskevas, I Zalonis, C Zournas
European Journal of Neurology 10 (2), 119-128, 2003
1112003
Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders
E Kapaki, J Segditsa, C Papageorgiou
Acta Neurologica Scandinavica 79 (5), 373-378, 1989
1061989
Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease-A consensus report
A Wallin, E Kapaki, M Boban, S Engelborghs, DM Hermann, B Huisa, ...
BMC neurology 17, 1-12, 2017
1052017
Novel mutations and repeated findings of mutations in familial Alzheimer disease
U Finckh, C Kuschel, M Anagnostouli, E Patsouris, GV Pantes, S Gatzonis, ...
Neurogenetics 6, 85-89, 2005
1052005
Increased cerebrospinal fluid tau protein in multiple sclerosis
E Kapaki, GP Paraskevas, M Michalopoulou, K Kilidireas
European neurology 43 (4), 228-232, 2000
1052000
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20